Recent Analysts’ Ratings Changes for Privia Health Group (PRVA)

Several analysts have recently updated their ratings and price targets for Privia Health Group (NASDAQ: PRVA):

• 2/28/2025 – Privia Health Group was given a new $29.00 price target on by analysts at JMP Securities.
• 2/28/2025 – Privia Health Group had its price target raised by analysts at Piper Sandler from $25.00 to $40.00. They now have an “overweight” rating on the stock.
• 2/28/2025 – Privia Health Group had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a “buy” rating on the stock.
• 2/28/2025 – Privia Health Group had its price target raised by analysts at Needham & Company LLC from $25.00 to $30.00. They now have a “buy” rating on the stock.
• 2/14/2025 – Privia Health Group had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $26.00 price target on the stock.
• 1/10/2025 – Privia Health Group is now covered by analysts at Needham & Company LLC. They set a “buy” rating and a $25.00 price target on the stock.

Privia Health Group Price Performance

PRVA stock traded down $0.01 during midday trading on Tuesday, hitting $23.96. The stock had a trading volume of 1,051,630 shares, compared to its average volume of 756,126. The company’s 50-day moving average price is $23.04 and its 200 day moving average price is $20.83. The firm has a market cap of $2.89 billion, a PE ratio of 239.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.

Institutional Trading of Privia Health Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PRVA. First Horizon Advisors Inc. grew its stake in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. purchased a new stake in Privia Health Group during the 4th quarter worth $51,000. Quarry LP boosted its holdings in Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the last quarter. Finally, KBC Group NV grew its holdings in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after acquiring an additional 871 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.